Viewing Study NCT06046794


Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-07-18 @ 8:45 AM
Study NCT ID: NCT06046794
Status: RECRUITING
Last Update Posted: 2025-06-11
First Post: 2023-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
Sponsor: Institut Paoli-Calmettes
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer Of Pancreas View
Keywords: